Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127684401 | 12768440 | 1 | I | 20120911 | 20160830 | 20160921 | 20160921 | EXP | DE-FRI-1000087588 | FOREST | 0.00 | A | M | Y | 0.00000 | 20160921 | OT | DK | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127684401 | 12768440 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | U | 20822 | ||||||||||
127684401 | 12768440 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | U | 20822 | ||||||||||
127684401 | 12768440 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | U | 0 | ||||||||||
127684401 | 12768440 | 4 | SS | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
127684401 | 12768440 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 0 | ||||||||||
127684401 | 12768440 | 6 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 0 | ||||||||||
127684401 | 12768440 | 7 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 0 | ||||||||||
127684401 | 12768440 | 8 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Sublingual | U | 0 | ||||||||||
127684401 | 12768440 | 9 | SS | BOCEPREVIR | BOCEPREVIR | 1 | Oral | U | 0 | 800 | MG | TID | |||||||
127684401 | 12768440 | 10 | SS | BOCEPREVIR | BOCEPREVIR | 1 | Oral | U | 0 | ||||||||||
127684401 | 12768440 | 11 | SS | PEGINTERFERON ALFA-2A | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127684401 | 12768440 | 1 | Depression |
127684401 | 12768440 | 3 | Headache |
127684401 | 12768440 | 4 | Product used for unknown indication |
127684401 | 12768440 | 5 | Chronic hepatitis C |
127684401 | 12768440 | 8 | Drug dependence |
127684401 | 12768440 | 9 | Chronic hepatitis C |
127684401 | 12768440 | 11 | Chronic hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127684401 | 12768440 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127684401 | 12768440 | Aggression | |
127684401 | 12768440 | Anaemia | |
127684401 | 12768440 | Chills | |
127684401 | 12768440 | Decreased appetite | |
127684401 | 12768440 | Depression | |
127684401 | 12768440 | Dermal cyst | |
127684401 | 12768440 | Dizziness | |
127684401 | 12768440 | Drug dependence | |
127684401 | 12768440 | Dysgeusia | |
127684401 | 12768440 | Fatigue | |
127684401 | 12768440 | Headache | |
127684401 | 12768440 | Influenza like illness | |
127684401 | 12768440 | Insomnia | |
127684401 | 12768440 | Leukopenia | |
127684401 | 12768440 | Myalgia | |
127684401 | 12768440 | Nausea | |
127684401 | 12768440 | Pruritus | |
127684401 | 12768440 | Pyrexia | |
127684401 | 12768440 | Skin disorder | |
127684401 | 12768440 | Thrombocytopenia | |
127684401 | 12768440 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127684401 | 12768440 | 1 | 2010 | 0 | ||
127684401 | 12768440 | 2 | 20120911 | 0 | ||
127684401 | 12768440 | 3 | 20130215 | 0 | ||
127684401 | 12768440 | 5 | 20120911 | 20121205 | 0 | |
127684401 | 12768440 | 6 | 20121206 | 20130207 | 0 | |
127684401 | 12768440 | 7 | 20130208 | 0 | ||
127684401 | 12768440 | 8 | 20120911 | 0 | ||
127684401 | 12768440 | 9 | 20121011 | 0 | ||
127684401 | 12768440 | 11 | 20120911 | 0 |